India Gives Nod To Moderna mRNA Covid-19 Vaccine, Cipla To Import Under Emergency Use

INDIA Team Latestly|

Drugs Controller General of India (DCGI) on June 29 granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna’s Covid-19 vaccine for restricted emergency use in the country. Cipla had earlier sought the DCGI nod for import & marketing authorisation of Moderna jabs in India. With Moderna’s approval, India now has four vaccines which have been granted emergency use authorisation, the other three being Covishield, Covaxin & Sputnik V. Meanwhile, India administered 33.79 lakh vaccine doses till 7 pm on June 29. India’s Covid-19 coverage has crossed the landmark of 33 crore. More than 9.19 crore vaccine doses have been administered in the age group of 18-44 so far, informed the Ministry of Health. More than 19.42 Lakh vaccine doses were administered to 18-44 age group for the first dose on June 29. Watch the video to know more

City Petrol Diesel
New Delhi 101.84 89.87
Kolkata 102.08 93.02
Mumbai 107.83 97.45
Chennai 102.49 94.39
View all
Company Price Change Value
Axis Banks 1050.00 50.00 533.00
Reliance 1050.00 33.00 533.00
Samsung 1050.00 33.00 533.00
Currency Price Change